| Molecular Formula | C27H41F2N5O |
| Molar Mass | 489.64 |
| Appearance | powder |
| Color | white to beige |
| Storage Condition | room temp |
| Use | Nirogacestat (PF-3084014) is an effective, orally active, reversible, non-competitive selective γ-secretase inhibitor with an IC50 of 6.2 nM. Nirogacestat inhibit Notch signaling pathway while minimizing gastrointestinal toxicity. It can be used to study Notch receptor-dependent tumors. |
| Target | γ secretase |
| HS Code | 29332900 |
| Reference Show more | 1. Wei P, et al. Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design. Mol Cancer Ther. 2010 Jun;9(6):1618-28. |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 2.042 ml | 10.212 ml | 20.423 ml |
| 5 mM | 0.408 ml | 2.042 ml | 4.085 ml |
| 10 mM | 0.204 ml | 1.021 ml | 2.042 ml |
| 5 mM | 0.041 ml | 0.204 ml | 0.408 ml |
| biological activity | Nirogacestat (PF-03084014, PF-3084014) is a selective gamma-secretase inhibitor, the IC50 in the cell-free assay was 6.2 nM. Nirogacestat (PF-03084014, PF-3084014) induced apoptosis. Phase 2. |
| Target | TargetValue gamma-secretase (cell-free assay) 6.2 nM |
| Target | Value |
| γ-secretase (cell-free assay) | 6.2 nM |